These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18756609)

  • 21. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
    Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R
    Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
    Nakamura M; Nagano H; Wada H; Noda T; Ota H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    J Gastroenterol; 2006 Nov; 41(11):1120-5. PubMed ID: 17160524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary malignant melanoma of the common bile duct: a case report and literature review.
    Bejarano González N; García Moforte N; Darnell Martín A; Dinarès Fernández MC; Laporte Roselló E; Navarro Soto S
    Gastroenterol Hepatol; 2005; 28(7):382-4. PubMed ID: 16137472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical prognostic factors in adjuvant melanoma trial.
    Nathanson L
    J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary malignant melanoma of the vagina with repeated local recurrences and brain metastasis.
    Lin LT; Liu CB; Chen SN; Chiang AJ; Liou WS; Yu KJ
    J Chin Med Assoc; 2011 Aug; 74(8):376-9. PubMed ID: 21872820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary pulmonary malignant melanoma: a clinicopathologic study of two cases.
    Gong L; Liu XY; Zhang WD; Zhu SJ; Yao L; Han XJ; Lan M; Li YH; Zhang W
    Diagn Pathol; 2012 Sep; 7():123. PubMed ID: 22992473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic analyses of benefit from interferon-alpha 2B in high-risk melanoma: trade-offs between completeness, simplicity and clarity.
    Hillner BE; Kirkwood JM
    Eur J Cancer; 1997 Aug; 33(9):1345-6. PubMed ID: 9337671
    [No Abstract]   [Full Text] [Related]  

  • 28. Node positive melanoma--a positive note?
    Kelly J; Kerin MJ
    Surgeon; 2012 Apr; 10(2):63-4. PubMed ID: 22385525
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of liver metastasis from anorectal malignant melanoma treated by chemoembolization].
    Izawa H; Souma I; Fukuchi N; Yoshida T; Ebisui C; Sakita I; Kanai T; Fujimoto T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2350-3. PubMed ID: 12484072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose adjuvant interferon for stage III malignant melanoma.
    Inman JL; Russell GB; Savage P; Levine EA
    Am Surg; 2003 Feb; 69(2):127-30. PubMed ID: 12641352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting report from the Third Global Workshop on Melanoma.
    Agarwala SS; di Pietro A; Flaherty KT; Garbe C; Grob JJ; Kashani-Sabet M; Kirkwood JM; Leachman S; Messina J; O'Day S; Ribas A; Sondak V
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-7. PubMed ID: 20718940
    [No Abstract]   [Full Text] [Related]  

  • 32. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvant interferon in the treatment of melanoma.
    Middleton MR
    Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.
    Grob JJ; Dreno B; de la Salmonière P; Delaunay M; Cupissol D; Guillot B; Souteyrand P; Sassolas B; Cesarini JP; Lionnet S; Lok C; Chastang C; Bonerandi JJ
    Lancet; 1998 Jun; 351(9120):1905-10. PubMed ID: 9654256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma.
    Messori A; Becagli P; Trippoli S; Tendi E
    Eur J Cancer; 1997 Aug; 33(9):1373-9. PubMed ID: 9337677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential chemotherapy and immunotherapy for the treatment of metastatic melanoma.
    Schuchter LM; Wohlganger J; Fishman EK; MacDermott ML; McGuire WP
    J Immunother (1991); 1992 Nov; 12(4):272-6. PubMed ID: 1477078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary malignant melanoma of the larynx.
    Amin HH; Petruzzelli GJ; Husain AN; Nickoloff BJ
    Arch Pathol Lab Med; 2001 Feb; 125(2):271-3. PubMed ID: 11175650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic melanoma of the vulva identified by peritoneal fluid cytology.
    Izban KF; Candel AG; Hsi ED; Selvaggi SM
    Diagn Cytopathol; 1999 Mar; 20(3):152-5. PubMed ID: 10086239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant therapy for high-risk primary and resected metastatic melanoma.
    Hersey P
    Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice.
    Ravaud A; Bedane C; Geoffrois L; Lesimple T; Delaunay M
    Br J Cancer; 1999 Aug; 80(11):1767-9. PubMed ID: 10468294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.